IL6 and COVID-19: This analysis aimed to characterize an early molecular serologic fingerprint of severe COVID-19 longitudinal disease courses and, in particular, to identify a multi-omic signature preceding hyperinflammation (denoted Δ IL-6) and COVID-19 coagulopathy (denoted Δ D-dimers) in patients with severe COVID-19.